Tanguler Tolga sold ALNY
October 2, 2025 · Form 4 insider transaction
Tanguler Tolga sold 1 shares of Alnylam Pharmaceuticals, Inc. at $457.64 per share, a transaction worth $457.64. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1
Price
$457.64
Total value
$457.64
InsiderTanguler Tolga
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after27,438
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of a tranche of PSUs granted to the reporting person on March 1, 2024.